1. Björkstén B, Clayton T, Ellwood P, Stewart A, Strachan D. ISAAC Phase III Study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol. 2008. 19:110–124.
Article
2. Aït-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J, et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009. 64:123–148.
Article
3. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001. 108:1 Suppl. S2–S8.
Article
4. Ahn K, Kim J, Kwon HJ, Chae Y, Hahm MI, Lee KJ, et al. The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: Nationwide cross-sectional survey using complex sampling design. J Korean Med Assoc. 2011. 54:769–778.
Article
5. Jáuregui I, Mullol J, Dávila I, Ferrer M, Bartra J, del Cuvillo A, et al. Allergic rhinitis and school performance. J Investig Allergol Clin Immunol. 2009. 19:Suppl 1. 32–39.
6. Woods L, Craig TJ. The importance of rhinitis on sleep, daytime somnolence, productivity and fatigue. Curr Opin Pulm Med. 2006. 12:390–396.
Article
7. Kim SY, Yoon SJ, Jo MW, Kim EJ, Kim HJ, Oh IH. Economic burden of allergic rhinitis in Korea. Am J Rhinol Allergy. 2010. 24:e110–e113.
Article
8. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol. 2001. 107:3–8.
Article
9. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy. 2007. 62:Suppl 85. 9–16.
Article
10. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007. 62:Suppl 85. 17–25.
Article
11. Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA, et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy. 2008. 63:842–853.
Article
12. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008. 63:Suppl 86. 8–160.
13. Hong SJ, Ahn KM, Lee SY, Kim KE. The prevalences of asthma and allergic diseases in Korean children. Korean J Pediatr. 2008. 51:343–350.
Article
14. Blaiss MS. Allergic rhinitis: direct and indirect costs. Allergy Asthma Proc. 2010. 31:375–380.
Article
15. Soni A. Medical Expenditure Panel Survey. Allergic rhinitis: trends in use and expenditures, 2000 and 2005. 2008. Rockville: Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality;(Statistical brief; No. 204).
16. National Health Insurance Corporation. Chung GH, Song JS, editors. National Health Insurance Statistical Yearbook. 2007. Seoul: Korea National Health Insurance Co.;488–489.
17. Lee SW, Lee KE, Park EH, Cho HS, Cha JK, Lee HR. A Survey on the use of alternative medicine in allergy patients. Pediatr Allergy Respir Dis. 2001. 11:249–259.
18. Jung JH, Lee JH, Kang IG, Cha HE, Kim ST. The present state of Korean traditional medicine and alternative medicine in nasal disease. Korean J Otorhinolaryngol-Head Neck Surg. 2010. 53:12–19.
Article
19. Ng TP, Wong ML, Hong CY, Koh KT, Goh LG. The use of complementary and alternative medicine by asthma patients. QJM. 2003. 96:747–754.
Article
20. Lee HJ, Lee JH, Lee YW, Kim CW, Dhong HJ, Park HS, et al. Multicenter analysis of the current status of unproved complementary/alternative medicine other than herbal medication in allergy patients. Korean J Med. 2011. 80:68–77.
21. Chang EY, Chung SW, Ahn KM, Lee SI. A study on the use of complementary alternative medicine in children with atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2005. 25:110–116.